Company Filing History:
11 out of 98 
2 out of 1,036 
1 out of 832,891 Years Active: 1997-2003
Title: Gregory S. Robinson: Innovator in Oligonucleotide Therapeutics
Introduction
Gregory S. Robinson is a prominent inventor based in Acton, MA (US), known for his significant contributions to the field of oligonucleotide therapeutics. With a total of 12 patents to his name, Robinson has made strides in developing innovative solutions for inhibiting tumor growth and addressing various disorders associated with neovascularization and angiogenesis.
Latest Patents
Among his latest patents, Robinson has developed "Modified VEGF Oligonucleotides for Inhibition of Tumor Growth." This patent discloses oligonucleotides that are complementary to VEGF-specific nucleic acids, which are useful in reducing the expression of VEGF. Additionally, he has created pharmaceutical formulations containing these oligonucleotides, aimed at treating disorders linked to neovascularization and angiogenesis. Another notable patent is "Antisense Oligonucleotide Inhibition of Vascular Endothelial Growth Factor Expression." This work highlights the role of Vascular Endothelial Growth Factor (VEGF) in abnormal angiogenesis associated with various pathological states. The disclosure presents compounds, compositions, and methods for inhibiting such abnormal angiogenesis, particularly through antisense oligonucleotides that bind to VEGF RNA and inhibit its expression.
Career Highlights
Throughout his career, Robinson has worked with notable organizations, including Hybridon, Inc. and Children's Medical Center Corporation. His work in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in oligonucleotide therapies.
Collaborations
Robinson has collaborated with esteemed colleagues such as Lois Elaine Smith and Adrienne P. Smyth, further enhancing the impact of his research and innovations in the medical field.
Conclusion
Gregory S. Robinson's work in the development of oligonucleotide therapeutics has positioned him as a key figure in the fight against cancer and other related disorders. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.